DRAP Achieves Major Milestone as Karachi Drug Lab Gets WHO Approval

🟢 Key Points

• DRAP achieved a major milestone in Pakistan’s healthcare system.
• Central Drugs Laboratory (CDL) Karachi received WHO prequalification.
• Certification confirms compliance with global quality standards.
• Ensures safer and more effective medicines in Pakistan.
• Strengthens Pakistan’s pharmaceutical sector globally.
• Government calls it a historic achievement for public health.

🟢 Summary

The Drug Regulatory Authority of Pakistan (DRAP) has achieved a significant milestone after the Central Drugs Laboratory in Karachi received World Health Organization (WHO) prequalification. This recognition confirms that Pakistan’s drug testing standards meet international benchmarks, ensuring better quality and safety of medicines for the public.

🟢 Detailed News

🔹 Historic Achievement in Healthcare

The Drug Regulatory Authority of Pakistan has reached a landmark milestone with its Central Drugs Laboratory in Karachi gaining approval from the World Health Organization. This certification places Pakistan among countries meeting top global standards in pharmaceutical testing.

🔹 What WHO Prequalification Means

The WHO prequalification confirms that medicines tested at the Karachi laboratory meet strict international standards for safety, quality, and effectiveness. This step ensures that patients across Pakistan receive reliable and high-quality medicines.

🔹 Boost for Pharmaceutical Industry

Officials stated that this achievement will strengthen confidence in Pakistan’s pharmaceutical sector and help local products compete in international markets. It also enhances trust among healthcare providers and patients.

🔹 Government’s Vision for Healthcare

Authorities described the milestone as part of broader healthcare reforms aimed at improving regulatory systems and ensuring access to safe medicines. The government emphasized shifting towards a more efficient and quality-focused healthcare system.

🔹 Impact on Public Health

Experts believe this development will play a key role in protecting citizens from substandard or unsafe medicines, marking a major step forward for Pakistan’s healthcare infrastructure.